Format

Send to

Choose Destination
See comment in PubMed Commons below
Antimicrob Agents Chemother. 2010 Dec;54(12):5376-8. doi: 10.1128/AAC.00857-10. Epub 2010 Sep 27.

Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin.

Author information

1
Division of Infection Diseases, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8051, Saint Louis, MO 63110-1093, USA. lmarcos@dom.wustl.edu

Abstract

Emerging infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) isolates are more likely to be associated with treatment failures than infections caused by other types of S. aureus. We present a case of pacemaker lead infective endocarditis caused by a non-daptomycin-susceptible strain of VISA. After 8 weeks of parenteral telavancin therapy, the patient achieved microbiological and clinical cure.

PMID:
20876369
PMCID:
PMC2981253
DOI:
10.1128/AAC.00857-10
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center